Zusammenfassung
Die Leitlinien zum diabetischen Fuss-Syndrom nehmen Bezug auf die entsprechenden präventiven, diagnostischen und therapeutischen Maßnahmen im Rahmen der umfassenden Betreuung des Diabetikers. Die diabetische Neuropathie und die periphere arterielle Verschlusserkrankung sind von grundlegender pathophysiologischer Bedeutung in der Entwicklung des diabetischen Fuss-Syndroms. Die motorische Neuropathie kann zu Deformitäten und Fehlbelastungen führen.
Summary
These are the guidelines for preventive care, diagnosis and treatment of the diabetic foot syndrome. Diabetic neuropathy, peripheral vascular disease, bone deformity and altered biomechanics are foot-related risk conditions. The position statement is focused on screening methods and recommendations for clinical care for diabetics, who currently have no foot ulcers. A decision pathway is offered with respect to diagnosis and management of diabetic patients at an increased risk or manifest injuries.
This is a preview of subscription content, log in via an institution to check access.
Literatur
Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. J Am Med Assoc. 2005;293:217–28.
Bakker K, Apelqvist J, Schaper NC. Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metabolism Res Rev. 2012;28 Suppl 1:225–31.
American Diabetes Association. Standards of medical care in diabetes − 2012. Diabetes Care. 2012;2012 Suppl 1:11–63.
Boulton AJM, Malik RAV, Arezzo JCA, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care. 2004;2004 27:1458–86.
Boulton AJ, Armstrong DG, Albert SF, et al. American Diabetes Association, American Association of Clinical Endocrinologists. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care. 2008;31:1679–85.
American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26:3333–41.
Mohler ER, 3rd, Treat-Jacobson D, Reilly MP, Cunningham KE, Miani M, Criquo MH, Hiatt WR, Hirsch AT. Utility and barriers to performance of the ankle-brachial index in primary care practice. Vasc Med. 2004;9:253–60.
Sanders LJ, Frykberg RG. Charcot neuroarthropathy of the foot. In: Bowker JH, Pfeifer MA, Herausgeber. Levin and O’Neals’s. The diabetic foot. 6. Aufl. St. Louis: CV Mosby; 2001. S. 439–66.
Valk GD, Kriegsman DM, Assendelft WJ. Patient education for prevention diabetic foot ulceration: a systematic review. Endocrinol Metab Clin N Am. 2002;31:633–58.
Schaper NC, Andros G, Apelqvist J, Bakker K, Lammer J, Lepantalo M, Mills JL, Reekers J, Shearman CP, Zierler RE, Hinchliffe RJ, et al. Specific guidelines for the diagnosis and treatment of peripheral arterial disease in a patients with diabetes and ulceration of the foot 2011. Diabetes Metab Res Rev. 2012;28 Suppl 1:236–7.
Game FL, Hinchliffe RJ, Apelqvist J, Armstrong DG, Bakker K, Hartemann A, Löndahl M, Price PE, Jeffcoate WJ. A Systematic review of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev. 2012;28 Suppl 1:119–41.
Author information
Authors and Affiliations
Corresponding author
Additional information
Für den Ausschuss Leitlinien
Rights and permissions
About this article
Cite this article
Lechleitner, M., Abrahamian, H. & Francesconi, M. Diabetischer Fuß. Wien Klin Wochenschr 124 (Suppl 2), 39–41 (2012). https://doi.org/10.1007/s00508-012-0264-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00508-012-0264-4